Artificial Activation of Escherichia coli mazEF and hipBA Toxin-Antitoxin Systems by Antisense Peptide Nucleic Acids as an Antibacterial Strategy

  • Front Microbiol. 2018 Nov 26:9:2870. doi: 10.3389/fmicb.2018.02870.
Marcin Równicki  1  2 Tomasz Pieńko  1  3 Jakub Czarnecki  4  5 Monika Kolanowska  1  6 Dariusz Bartosik  4 Joanna Trylska  1
Affiliations
  • 1. Centre of New Technologies, University of Warsaw, Warsaw, Poland.
  • 2. College of Inter-Faculty Individual Studies in Mathematics and Natural Sciences, University of Warsaw, Warsaw, Poland.
  • 3. Department of Drug Chemistry, Faculty of Pharmacy with the Laboratory Medicine Division, Medical University of Warsaw, Warsaw, Poland.
  • 4. Department of Bacterial Genetics, Institute of Microbiology, Faculty of Biology, University of Warsaw, Warsaw, Poland.
  • 5. Unit of Bacterial Genome Plasticity, Department of Genomes and Genetics, Pasteur Institute, Paris, France.
  • 6. Genomic Medicine, Medical University of Warsaw, Warsaw, Poland.
Abstract

The search for new, non-standard targets is currently a high priority in the design of new Antibacterial compounds. Bacterial toxin-antitoxin systems (TAs) are genetic modules that encode a toxin protein that causes growth arrest by interfering with essential cellular processes, and a cognate antitoxin, which neutralizes the toxin activity. TAs have no human analogs, are highly abundant in Bacterial genomes, and therefore represent attractive alternative targets for antimicrobial drugs. This study demonstrates how artificial activation of Escherichia coli mazEF and hipBA toxin-antitoxin systems using sequence-specific antisense peptide nucleic acid oligomers is an innovative Antibacterial strategy. The growth arrest observed in E. coli resulted from the inhibition of translation of the antitoxins by the antisense oligomers. Furthermore, two Other targets, related to the activities of mazEF and hipBA, were identified as promising sites of action for antibacterials. These results show that TAs are susceptible to sequence-specific antisense agents and provide a proof-of-concept for their further exploitation in antimicrobial strategies.

Keywords
Escherichia coli mazEF and hipBA targets; antimicrobial strategies; antisense oligonucleotides; bacterial toxin–antitoxin systems; peptide nucleic acid (PNA).
Products